The intracellular plasma membrane-connected compartment in the assembly of HIV-1 in human macrophages
© Nkwe et al. 2016
- Received: 5 May 2016
- Accepted: 9 June 2016
- Published: 23 June 2016
In HIV-infected macrophages, newly formed progeny virus particles accumulate in intracellular plasma membrane-connected compartments (IPMCs). Although the virus is usually seen in these compartments, it is unclear whether HIV assembly is specifically targeted to IPMCs or whether some viruses may also form at the cell surface but are not detected, as particles budding from the latter site will be released into the medium.
To investigate the fidelity of HIV-1 targeting to IPMCs compared to the cell surface directly, we generated mutants defective in recruitment of the Endosomal Sorting Complexes Required for Transport (ESCRT) proteins required for virus scission. For mutants unable to bind the ESCRT-I component Tsg101, HIV release was inhibited and light and electron microscopy revealed that budding was arrested. When expressed in human monocyte-derived macrophages (MDM), these mutants formed budding-arrested, immature particles at their assembly sites, allowing us to capture virtually all of the virus budding events. A detailed morphological analysis of the distribution of the arrested viruses by immunofluorescence staining and confocal microscopy, and by electron microscopy, demonstrated that HIV assembly in MDMs is targeted primarily to IPMCs, with fewer than 5 % of budding events seen at the cell surface. Morphometric analysis of the relative membrane areas at the cell surface and IPMCs confirmed a large enrichment of virus assembly events in IPMCs.
Serial block-face scanning electron microscopy of macrophages infected with a budding-defective HIV mutant revealed high-resolution 3D views of the complex organisation of IPMCs, with in excess of 15,000 associated HIV budding sites, and multiple connections between IPMCs and the cell surface.
Using detailed quantitative analysis, we demonstrate that HIV assembly in MDMs is specifically targeted to IPMCs. Furthermore, 3D analysis shows, for the first time, the detailed ultrastructure of an IPMC within a large cell volume, at a resolution that allowed identification of individual virus assembly events, and potential portals through which virus may be released during cell-cell transfer. These studies provide new insights to the organisation of the HIV assembly compartments in macrophages, and show how HIV particles accumulating in these protected sites may function as a virus reservoir.
- Assembly compartment
- Intracellular plasma membrane-connected compartments
- Endosomal sorting complexes required for transport
- Volume electron microscopy
HIV primarily infects activated T cells, in particular effector memory T cells, and macrophages expressing CD4 and the co-receptor CCR5 (Reviewed in [1–3]). Subsequently, following replication, progeny viruses are produced through the assembly of the main viral components at the plasma membrane of infected cells. A key difference in HIV assembly in these different host cells is that, in mature macrophages, newly formed virions accumulate in characteristic highly interconnected intracellular compartments [4–9]. Many of these compartments have been shown to be connected to the plasma membrane, so that they are now known as intracellular plasma membrane-connected compartments (IPMCs). The compartments contain various markers typical of the plasma membrane, including proteins such as CD44, the tetraspanins CD9, CD81 or CD53 [4, 10], as well as β2 integrins (CD18 with CD11b and/or CD11c) and associated proteins that can form focal adhesion-like structures [7, 9] or the scavenger receptor CD36 . In addition, the plasma membrane and IPMC membranes both contain cholesterol and phosphatidylinositol-4,5-bisphosphate [PtdIns(4,5)P2] [3, 9]. Similar compartments are present in differentiated/mature uninfected monocyte-derived macrophages (MDMs), but are expanded upon HIV infection [4, 7, 10, 11]. In addition, similar compartments have been seen in lymph node macrophages in vivo  or in isolated placental Hoffbauer cells , and appear also to be present in gut-associated lymphoid tissue of HIV-infected humanized mice . Notably, when HIV-infected MDMs interact with autologous CD4+ T cells, viruses contained within IPMCs can be released through virological synapses leading to efficient infection of the T cells [15–18]. Macrophages become prominent target cells of HIV in advanced disease and AIDS, when CD4+ T cells are depleted . In particular, HIV-infected monocytes invading the brain differentiate to macrophages that mediate neuroinflammation and contribute to pathogenesis and HIV-associated neurocognitive disorders (reviewed in [20–22]). Furthermore, these cells may represent a viral reservoir at this immunologically privileged site [23, 24].
HIV assembly is targeted to the plasma membrane via PtdIns(4,5)P2, which binds the Matrix (MA) domain of the main virally encoded structural protein p55Gag [25–27]. As PtdIns(4,5)P2 has been shown to be present in IPMCs, as well as at the cell surface proper, both locations should be able to support virion formation. However, the fate of viruses budding at the cell surface or within IPMCs would differ, in that viruses assembling at the cell surface would be released into the extracellular fluids and may be able to infect other distant cells via cell-free infection. By contrast, viruses that accumulate in IPMCs could be stored in an infectious form for extended periods of time  and may be a source of virus for direct cell-to-cell transmission to non-infected target cells. Despite these different viral fates, to date, there has not been a rigorous analysis to address whether, in infected macrophages, HIV assembles primarily within IPMCs or whether a proportion assembles at the cell surface and is released directly into the medium.
Herein, we have addressed this question by generating HIV-1 mutants defective in the recruitment of Endosomal Sorting Complexes Required for Transport (ESCRT) proteins required for virus scission [29, 30] (reviewed in ). When expressed in MDMs, these mutant viruses formed immature virus buds that were arrested at their budding sites, allowing the visualisation of all virus assembly events. Detailed analysis of HIV assembly sites by confocal imaging and by electron microscopy (EM) demonstrated that HIV assembly in MDMs is targeted primarily to the IPMCs. Furthermore, using serial block-face scanning EM of MDMs infected with a budding-defective HIV mutant, we constructed a high-resolution 3-dimensional (3D) model of the complex organisation of the IPMC in relation to the cell surface and mapped the associated HIV budding sites. These studies indicate that, in infected mature MDMs, HIV assembly is targeted to IPMCs, provide a deeper understanding of the organisation of the HIV assembly compartments in MDMs, and show how infected macrophages accumulating HIV particles in these protected sites may function as a virus reservoir.
Generation of budding-arrested HIV-1 proviruses
HIV requires the ESCRT machinery to complete budding and release free virions [31–34]. Thus, we exploited the ability to inhibit recruitment of the ESCRT machinery to arrest virus budding and allow analysis of all the sites where virus assembly is targeted in MDMs. Although ESCRT components, such as Tsg101 (tumour susceptibility gene 101) and/or ALIX (ALG-2-interacting protein X), were efficiently depleted by siRNA, we observed little effect on virus release (Additional file 1: Figure S1), which probably reflects the difficulty of achieving effective knockdown of the ESCRT proteins in the cells infected with HIV.
Similar cultures of HEK 293 T cells were processed for morphological analysis either by cryosectioning and immunolabelling, or embedding in Epon for EM. Analysis of semi-thin immunolabelled cryosections by fluorescence microscopy showed frequent infected cells, identified by cytoplasmic p24/p55 Gag labelling (Fig. 1b). Assembling virus particles appeared as brightly stained puncta at the cell surface (see p24/p55 panels, green). Notably, for cells transfected with HIV-1 R3A wild type (WT), some of these puncta could be co-labelled with an antibody (mAb 4C9) that is specific for the proteolytically cleaved MA protein p17 (red), indicating that they are mature or maturing virions. While p55-stained cell surface particles were also seen for cells transfected with the PTAP– or Δp6 proviruses, consistent with virus budding, these failed to co-label for p17, indicating that they had not undergone maturation. A budding arrested phenotype was directly confirmed by EM (Fig. 1c). Cells expressing R3A WT contained few virus particles, although some mature virions could be found, for example trapped between cells. For cells transfected with the mutant proviruses we only observed arrested buds with various degrees of curvature and lined with the thick Gag layer characteristic of immature HIV particles. This demonstrated that proviral clones unable to recruit Tsg101 (the PTAP– and Δp6 mutants) were indeed arrested late during particle assembly, with incomplete, immature particles retained at their cell surface budding sites.
Expression of budding-arrested HIV proviruses in primary MDMs
Cultures of transfected MDMs were also fixed and immunolabelled with antibodies against the hyaluronic acid receptor CD44, a marker of the plasma membrane and IPMCs, and against Gag p24/p55, to identify infected cells and determine the location of the virus particles or buds, and analysed by confocal microscopy (Fig. 2b). For MDMs transfected with HIV-1 R3A WT, or the PTAP– or Δp6 mutants, infected cells were seen in the cultures, and in all cases puncta of Gag p24/p55 staining were located primarily within CD44+ IPMC structures (Fig. 2b). Only a few cells expressed the Δp6 mutant, precluding any quantitative analysis. For the WT and PTAP– transfections, coverslips were systematically searched and any Gag-expressing cells scored for whether Gag puncta were seen exclusively within CD44+ IPMCs, at the cell surface, or at both locations. This revealed that, in most MDMs, virus staining was only detected in the IPMCs (60 % and 72 % of cells, respectively, Fig. 2c), suggesting that virus assembly is targeted to this site. Notably, those cells in which virus staining was seen exclusively at the cell surface lacked detectable intracellular CD44+ IPMCs.
For more quantitative analysis of the levels of viruses in infected cells, we recorded complete confocal z-stacks from random fields of infected MDMs, and measured the total fluorescence intensity for p24/55 and p17 staining of the infected cells (Additional file 4: Figure S4B and C, respectively). This confirmed strong labelling for viral p24/p55, though with somewhat stronger labelling of cells infected with WT virus compared to the PTAP–YP– mutant (Additional file 4: Figure S4B). By contrast, strong labelling with the anti-p17 antibody specific for the cleaved MA was only seen for MDMs infected with R3A WT, while cells infected with the PTAP–YP– mutant had rare p17-stained puncta, consistent with occasional events where HIV protease may have been activated prematurely in the bud  (overall ratio of fluorescence intensity of WT to PTAP–YP– mutant approximately equal to 7×) and many cells infected with the PTAP–YP– lacked p17 fluorescence (Additional file 4: Figure S4C). This supports the notion that the PTAP–YP– virus buds are arrested prior to bud scission, and consequently also to proteolytic maturation. In these MDMs the immunostained virus puncta were also located primarily in IPMCs. For cells where the 3D confocal stacks indicated virus staining both in the IPMC and at the cell surface (and where IPMCs were clearly separated from the cell surface), the IPMC staining was segmented and measured relative to the total p24/p55 fluorescence of the cell. This demonstrated that, on a per cell basis, more than 90 % of the virus labelling was in IPMCs (Fig. 3g). Thus, for MDMs that express IPMC domains, the IPMC is the main site where HIV assembles. The higher levels of cell surface viruses on cells infected with HIV-1 WT is consistent with higher levels of infection and larger numbers of viruses, and suggests that some HIV particles may be re-directed to the PM as the IPMC becomes crowded.
These studies strongly support the view that HIV is predominantly assembled at IPMCs in primary human macrophages.
Ultra-structural analysis of HIV assembly sites in infected primary MDMs
Quantitation of virus buds and membrane lengths for cryosections of MDMs infected with budding-arrested HIV-1 mutants
No. of cell profiles analyseda
% of buds in IPMC
Enrichment of buds in IPMCb
No. of virus buds
μm of membrane
Buds/μm of membrane
No. of virus buds
μm of membrane
Buds/μm of membrane
Imaging HIV assembly sites by serial block-face EM and 3D reconstruction
We also analysed the locations of the budding HIV particles in relation to the IPMC and cell surface membranes. Immature virus particles were found throughout the IPMC, including the channels, branching membrane mesh-works and connections towards the cell surface, indicating that all parts of the IPMC have the potential to support HIV budding. Although most of the cell surface was devoid of viral budding profiles, some buds were noted at the cell surface in higher sections near the top of the cell (Fig. 6i and Additional files 6, 7, 8 and 9). Altogether, we identified 15,264 virus particles in the IPMC and 2085 particles at the cell surface and among the membrane protrusions and blebs, with surface virus buds representing about 12 % of the total viruses in the images from this cell. Notably, these virus buds were not distributed evenly over the cell surface, but appeared concentrated around sites where the IPMC joins the cell surface (Fig. 6k–m and Additional file 8: Figure S6 and Additional file 9: Movie S2). The arrangement of virus buds seen in this cell corresponds to the various different arrangements of buds in IPMCs or at the cell surface seen on the cryosections (see above), where we observed cell profiles with IPMCs deep in the juxta-nuclear area, or close to and connecting with the cell surface.
Notably, since this analysis was done on MDMs infected with mutant HIV unable to complete budding, virtually all assembly events should have been captured for analysis. The predominant localization of HIV buds in IPMCs, seen by immunofluorescence and confocal microscopy, as well as different EM methods, suggests that HIV assembly is specifically targeted to the IPMCs in MDMs.
In this study, we have addressed the question of whether HIV assembly in MDMs preferentially takes place in the IPMCs, or whether the virus also assembles directly at the cell surface and is immediately released into the medium. Using HIV mutants unable to complete the ESCRT-dependent scission reaction, we arrested viruses at their budding sites, which allowed us to capture essentially all HIV assembly events. Analysis of infected cells by confocal microscopy, or of ultrathin cryosections by transmission EM, showed fewer than 5 % of HIV buds at the cell surface and revealed a large enrichment of immature viruses in the IPMCs. Similarly, reconstruction of an infected macrophage by serial block-face scanning EM revealed the intricate structure of the virus-filled IPMC, with cell surface virus buds located predominantly near connections between the IPMC and the cell surface.
The ability to arrest virus budding by mutating the ESCRT-interacting motifs in the p6 portion of Gag confirms that, as in other systems, the ESCRT machinery is also essential for HIV budding in MDMs [8, 11, 29, 38]. For the PTAP– and PTAP–YP– mutants, we only detected immature budding profiles. This was clear from staining with an antibody to p17 that only detects the cleaved MA protein. The HIV protease is only active as a dimer, and Gag proteolysis is generally believed to occur concomitant with or shortly after bud scission when the GagPol precursors are able to interact and initiate proteolysis . Although we generally saw little MA staining in cells expressing the budding-arrested HIV mutants, we did notice occasional cleavage in arrested buds, particularly in cells expressing very high levels of Gag. Overall, in MDMs infected with the PTAP–YP– mutant, levels of the processed MA were reduced more than 7-fold (Additional file 4: Figure S4C); furthermore, at the EM level, we never detected particles with clear virus cores.
To identify in detail the sites of HIV assembly, large numbers of MDMs isolated from eight different blood donors were analysed by immunofluorescence confocal microscopy and more than 1000 cells were scored for virus distributions (Figs. 2 and 3). Importantly, immunofluorescence staining for Gag p24/55 revealed accumulations of viruses in IPMCs both in MDMs transfected with HIV proviruses and fixed after 24 h (Fig. 2), as well as in cells infected with WT or rescued ESCRT mutant virus preparations and examined 7 days post-infection (Fig. 3). This indicates that virus targeting to the IPMCs is not dependent on how long the cells have been infected. Furthermore, ultrathin cryosections of infected MDMs from four of these donors were studied by EM (Figs. 4 and 5, and Table 1). HIV buds were seen almost exclusively in the IPMCs, indicating that, in MDMs where IPMCs were present, HIV assembly is directed to these compartments. Although all these studies were on fixed cells, live cell imaging studies with Gag-GFP also suggest that Gag assembly is first detected in the IPMCs [8, 9]. Together, these studies show that the accumulations of intracellular HIV particles in MDMs are due to direct targeting of virus budding to the IPMCs and not to extensive internalisation of virus particles.
It is not clear how the virus targets IPMC membranes in preference to the cell surface. Gag binding to the cytoplasmic face of the plasma membrane requires PtdIns(4,5)P2, but since PtdIns(4,5)P2 is also present at the cell surface , there must be other distinguishing features between the membranes of IPMCs and the cell surface. It is possible that there may be variation in the local PtdIns(4,5)P2 concentration, or differences in the PtdIns(4,5)P2 fatty acid chains that may contribute to local heterogeneity in membrane fluidity or lipid phases (see ), allowing stronger Gag binding to IPMCs. Most cellular proteins that have been identified in the IPMCs are also present at the cell surface [4, 7, 10, 11], though again there may be differences in the local abundance of these proteins.
Since it became clear that the virus-containing compartments in MDMs are actually connected to the cell surface [4, 10], there have been studies to delineate the fine structure of these compartments at the EM level. For analysis of the 3D structure of the IPMCs, imaging approaches have included ion-abrasion scanning EM , EM tomography  or serial section transmission EM , which all revealed the complex organisation of the IPMCs with many internal membranes and convoluted interconnected membrane mesh-works. Our serial block-face scanning EM imaging provides a significantly more comprehensive view of IPMCs. We have been able to image a much larger volume than was achieved in previous studies (>50,000 μm3), at a resolution comparable to EM tomography. Our studies revealed the major portion of a large IPMC in which we were able to identify and count individual immature virus buds. The overall structure of the compartment resembles IPMCs revealed by fluorescence staining with various membrane dyes or the PtdIns(4,5)P2-binding pleckstrin homology domain of phospholipase Cδ , but the method also revealed the finer channels and connections, especially in the upper mesh-like portion of the IPMC (marked as Portion II in Fig. 6). We have also been able to define the surface connections where IPMCs open to the exterior of the cell, including a single channel from one part of an IPMC opening in the deep fold between bleb-like cell surface protrusions, or a very complex branching and anastomosing membrane web merging with the upper surface of a cell.
Overall, we have been able to identify more than 15,000 immature virus buds in this IPMC, associated with all parts of the structure, although the densities of the buds varied in different parts of the IPMC. Since the very basal portion of the IPMC is missing from our model, this cell would have even more intracellular virus particles. We also analysed viruses at the cell surface and found that they were highly concentrated above the areas where the IPMC opens to the cell surface. Many particles were seen in groups and clusters, sometimes attached to remaining membrane extensions. This was true for the channel connection (Arrowheads in Fig. 6 – note the two small groups of viruses above the channel opening, but as the channel opening is hidden deep between large membrane blebs, only the upper cluster of virus buds is visible from the cell surface) as well as for the larger accumulations of surface virus buds over the centre of the cell above the larger part of the IPMC. Normally, these viruses would be released into the medium and not be observed, but here the use of budding-arrested mutants has allowed us to define in detail the sites where viruses are able to exit the IPMCs.
Although we have only been able to analyse one cell at this resolution, the structure of the IPMC in this cell reflects arrangements of IPMC structures and viral budding sites seen for the MDM profiles analysed for the cryosections (Figs. 4, 5 and Additional file 5: Table S1), where we were able to examine multiple cells from several donors. Here, we observed cell profiles with deep IPMCs removed from the cell surface (e.g. Fig. 4e, f) or others close to and connecting to the cell surface (e.g. Fig. 5e–g) and cell profiles with channel-like connections to the cell surface (not shown). Notably, we even detected two cell profiles that lacked IPMCs (in the sectioned area), but with immature arrested HIV buds among cell surface membrane sheets and microvilli (Additional file 5: Table S1: D429 cell profiles 18 and 26, with virus only at the cell surface) revealing the sensitivity of the correlative EM analysis and demonstrating that we were not biased towards cell profiles with viruses in IPMCs for this analysis. In addition, the cryosection dataset included a number of cells with prominent cell surface blebs. Together with other published information, the cell shown in Fig. 6 appears to be representative of a typical HIV-infected macrophage in culture.
Macrophages play key roles in HIV infection. Tissue macrophages are found in all parts of the body, and are able to transfer viruses to T cells via virological synapses. As infected macrophages are relatively long-lived, they are able to store and archive infectious virus particles, and they may be particularly important in disseminating viruses late in HIV infection in the brain. The present study reveals the detailed structure of the IPMC and demonstrates that HIV is specifically targeted to this compartment. Understanding the structure of the IPMCs may also shed light on the role of HIV-infected macrophages as a virus reservoir – the assembled virus particles appear sequestered within the IPMC environment, largely protected from the immune response , but able to infect CD4+ T cells following regulated release of HIV via virological synapses [17, 18]. In this way, macrophages and their specialised IPMCs directly contribute to HIV pathogenesis.
To investigate the fidelity of HIV-1 targeting to IPMCs in human MDMs, we used mutants unable to complete the ESCRT-dependent scission reaction to arrest viruses at their budding sites, allowing us to capture all HIV assembly events. Detailed morphological analysis of the distribution of the budding-arrested viruses by immunofluorescence staining and confocal microscopy, as well as by EM, showed fewer than 5 % of the HIV buds at the cell surface, thereby demonstrating specific targeting of HIV assembly to IPMCs. High resolution reconstruction and segmentation of an infected macrophage by serial block-face scanning EM revealed the detailed ultrastructure of an IPMC within a large cell volume, and allowed us to observe the location of individual budding events. These studies demonstrate that HIV assembly is specifically targeted to complex IPMCs and indicates HIV particles stored in these protected sites may function as virus reservoirs.
Reagents and antibodies
Unless indicated otherwise, tissue culture media and supplements were obtained from Life Technologies (Paisley, UK), tissue culture plastic from Thermo Fisher Scientific (Cramlington, UK) or Techno Plastic Products AG (Trasadingen, Switzerland) and chemicals were obtained from Sigma-Aldrich (Dorset, UK). Restriction enzymes and the DNA ladder were purchased from Promega (Southampton, UK) and EM chemicals and supplies from Agar Scientific (Stansted, UK) or TAAB Laboratories (Reading, UK).
Antibodies against HIV-1 p24/p55 (38:96 K and EF7, ARP365 and ARP366, respectively), p17 (4C9, ARP342) or Env (2G12, ARP3064) were obtained from the National Institute for Biological Standards and Control, Center for AIDS Reagents (NIBSC CFAR, South Mimms, UK; http://www.nibsc.org/science_and_research/virology/centre_for_aids_reagents.aspx). The mouse monoclonal antibody Kal-1 against HIV-1 p24 was from Dako (Thetford, UK; Dako Cat# M0857, RRID:AB_2335686). The rabbit polyclonal anti-ALIX antibody was a gift from Wes Sundquist (University of Utah, Salt Lake City, USA). Anti-CD44 (MEM-85; Abcam Cat# ab2212 RRID:AB_302891) and anti-VDAC-1 (ab15895; Abcam Cat# ab15895 RRID:AB_2214787) were from Abcam Ltd. (Cambridge, UK), anti-Tsg101 (M-19) from Santa Cruz Biotechnology (Cat# sc-6037 RRID:AB_2208099), and mouse anti-adaptin-γ (clone 88; BD Bioscience Cat# 610386 RRID:AB_397769) from BD Bioscience. Horseradish peroxidase-conjugated goat anti-mouse and anti-rabbit were purchased from Life Technologies (Thermo Fisher Scientific #32430 RRID:AB_1185566; #31460 RRID:AB_228341, respectively), horseradish peroxidase-conjugated donkey anti-goat from Santa Cruz (Santa Cruz #sc-2020 RRID:AB_631728) and the Alexa Fluor-labelled secondary antibody reagents were from Life Technologies (Thermo Fisher Scientific #A21121 RRID:AB_2535764; #A21134 RRID:AB_10393343; #A21242 RRID:AB_2535811; #A21135 RRID:AB_2535774; #A11037 RRID:AB_2534095 and A11059 RRID:AB_2534106).
Cell lines and macrophage preparation
HEK 293 T and TZM-bl cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10 % v/v fetal bovine serum (FBS), 2 mM L-glutamine, 100 units/mL penicillin and 100 μg/mL streptomycin. MDMs were prepared from peripheral blood mononuclear cells isolated from buffy coats obtained from healthy blood donors (National Blood Services, Essex, UK) as described previously [7, 18]. Monocytes were differentiated with macrophage-colony stimulating factor (M-CSF, 10 ng/mL; R&D Systems, Abington, UK) and cultured in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10 % human serum, 100 units/mL penicillin and 100 μg/mL streptomycin.
Plasmids and viruses
The HIV-1 construct pNL4.3-R3A, a chimeric virus containing the env gene of the HIV-1 R3A strain  in the NL4.3 backbone, was a gift from J. Hoxie (University of Pennsylvania, Philadelphia, USA). A Gag fragment containing the entire p6 domain was excised from pNL4.3-R3A with EcoRI and ApaI and subcloned into pEGFP-Nl (Addgene). Using the QuickChange® Site-Directed Mutagenesis Kit (Agilent Technologies, Wokingham, UK), the new plasmid carrying the EcoRI/ApaI fragment from pNL4.3-R3A (hereafter, called “carrier plasmid”) was mutagenised at the PTAP and YP residues, or a stop codon was introduced at the beginning of p6 using the following primers (5′ to 3′): R3A_PTAP forward, TTTTCTTCAGAGCAGACCAGAGCTAATACGCCTACCAGAAGAGAGCTTCAGGTTTG; R3A_PTAP reverse, CAAACCTGAAGCTCTCTTCTGGTAGGCGTATTAGCTCTGGTCTGCTCTGAAGAAAA; R3A_YP forward, CGATAGACAAGGAACTGTCTCGTTTAGCTTCCCTCAGATC; R3A _YP reverse, GATCTGAGGGAAGCTAAACGAGACAGTTCCTTGTCTATCG; R3A_p6Del forward, CCCACAAGGGAAGGCCAGGGAATTTTTAACAGAGCAGACCAGA; R3A_p6Del reverse, TCTGGTCTGCTCTGTTAAAAATTCCCTGGCCTTCCCTTGTGGG. The mutagenised carrier fragments were excised from the carrier plasmid and re-inserted into pNL4.3-R3A, generating the mutant proviruses YP−, PTAP−, PTAP−YP− and Δp6. pCMVGag WT was generated from Gag-GFP in pEGFP-N1 (Herminda-Matsumoto and Resh 2000, provided by W. Sundquist) by deleting the GFP sequence. Stocks of infectious HIV-1 R3A PTAP− or PTAP−YP− were prepared by transfecting HEK 293 T cells with a mixture of pNL4.3-R3A PTAP− or PTAP−YP− and pCMVGag WT. After 24 h, media were collected, the rescued viruses were purified by ultracentrifugation through a 20 % w/v sucrose cushion and stored frozen in RPMI 1640. Virus titres were measured on TZM-bl indicator cells, using the Galacto-Star Reporter Gene Assay System (Life Technologies) as previously described [7, 18].
Infections and transfections
HEK 293 T cells were transfected with FuGENE HD (Roche, Welwyn Garden City, UK). Fourteen-day-old MDMs were transfected by electroporation using the Amaxa Human Macrophage Nucleofector Kit and Amaxa Nucleofector II (Lonza, Kent, UK), and incubated as described . MDMs were infected with HIV-1 WT or the mutant viruses at 3 and 6 focus forming units per cell (FFU/cell), respectively, by spinoculation (centrifugation at 1300 g and 25 °C for 2 h) and cultured for 7 days as described .
Analysis of HIV release
For released viruses, culture supernatants were cleared by centrifugation, overlaid onto 20 % sucrose in PBS and centrifuged at 100,000 g for 2 h at 4 °C. Cells were washed in PBS and cells or the purified virus pellets were lysed in Laemmli reducing sample buffer (Sigma-Aldrich, Dorset, UK), heated for 10 min at 95 °C and resolved, blotted and analysed with appropriate antibodies as described before [7, 9, 18]. Signal intensities on western blots were quantified using ImageJ. Virus release efficiencies were calculated as the amount of p24 + p55 in the virus blot relative to the total p24 and p55 in cell and virus lysates.
MDMs on coverslips were fixed in 4 % formaldehyde, washed, quenched in 50 mM NH4Cl in PBS and permeabilized with 0.1 % Triton X-100 in blocking buffer (6 mg/mL purified human IgG and 0.5 % BSA in PBS). Cells were incubated in primary and secondary antibodies as described previously [7, 9]. Nuclei were counter-stained with 0.5 μg/mL Hoechst 33258 (Life Technologies), and the coverslips were mounted with Mowiol (Merck Millipore, Darmstadt, Germany). Confocal images were acquired with a Leica TCS SP3 confocal microscope, 63× oil objective and Leica LAS AF Software (Leica Microsystems, Milton Keynes, UK). Images were processed using ImageJ and assembled using Adobe Illustrator CS4.
Preparation of cells for cryosectioning and EM immunolabelling
Cells were prepared for cryosectioning as previously described [4, 7]. Briefly, cells were fixed in 4 % formaldehyde in 0.1 M sodium phosphate buffer, pH 7.4, embedded in 12 % gelatine, infiltrated with 2.3 M sucrose and frozen in liquid nitrogen. Samples were screened by immunofluorescence staining of semi-thin cryosections (0.5 μm) as described  and imaged with an Axioskop microscope (Carl Zeiss, Hertfordshire, UK) fitted with a charge-coupled device camera (Orca-ER; Hamamatsu), controlled by OPENLAB 5.0.2 software (Improvision, Perkin Elmer). Images were processed using Adobe Photoshop CS4.
EM immunolabelling was as described [4, 44, 45]. Briefly, ultrathin cryosections (~50 nm) on formvar/carbon-coated EM grids or H6 finder grids were quenched in 50 mM glycine/50 mM NH4Cl, washed and stained with mouse antibodies to p24/p55 prepared in 2 % BSA, 0.2 % acetylated BSC (BSA-c, Aurion, Wageningen, The Netherlands) in PBS, rabbit anti-mouse Alexa-488 and Protein A-gold (PAG, The EM Lab, Utrecht University, The Netherlands). Some grids were double labelled with antibodies to HIV Env, fixed in 1 % glutaraldehyde, washed, quenched and then stained for p24/p55, as above . For correlative on-grid light and EM, sections were incubated with Hoechst 33258 to stain the nuclei, mounted in 50 % glycerol in H2O and fluorescent cells were imaged with an Axioskop microscope (Zeiss) as above. All sections were stained with 2 % neutral uranyl acetate and embedded in 0.4 % uranyl acetate in 2 % methylcellulose . Specimens were examined with a Tecnai 20 (FEI, Eindhoven, The Netherlands) using a Morada camera and iTEM software (Olympus Soft Imaging Solutions), and processed with Adobe Photoshop CS4.
Conventional EM of Epon-embedded cells
HEK 293 T cells were fixed for 30 min in 1.5 % glutaraldehyde, 4 % formaldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, post-fixed in reduced osmium (1.5 % potassium ferricyanide, 1 % osmium tetroxide) at 4 °C for 1 h, and treated with 1 % tannic acid in 0.05 M sodium cacodylate for 45 min in the dark. The cells were washed with 1 % sodium sulphate in 0.05 M sodium cacodylate, and dehydrated and embedded in Epon 812 resin. Ultrathin sections were stained with lead citrate and imaged with a Tecnai 20 EM as above.
Serial block-face scanning EM
Seven-day-old MDMs were infected with HIV-1 R3A PTAP−YP− for 7 days and incubated in 5 μg/mL CellMask orange plasma membrane stain (Invitrogen Molecular Probes, Paisley, UK) for 10 min at 37 °C. Cells were fixed in 4 % formaldehyde, washed and imaged on an inverted light microscope (DMIL LED; Leica, Vienna, Austria) to identify cells with IPMCs, and bright-field and fluorescence images of the cells of interest were acquired at low magnification. To mark the selected cells, a ring of adjacent cells was removed by scratching manually with forceps. This allowed the region of the coverslip (and later, the resin block) containing the cell of interest to be easily visible to the naked eye, once the cells were osmicated. Cells were then further fixed with 2 % formaldehyde, 1.5 % glutaraldehyde and incubated with reduced osmium at 4 °C. The cells were treated with 1 % thiocarbohydrazide, before a 30 min incubation in 2 % osmium tetroxide and an overnight treatment with 1 % uranyl acetate. A final en bloc stain was performed with lead aspartate before the sample was dehydrated in ethanol and embedded in Durcupan resin.
Embedded EM blocks were examined to identify the cells of interest, trimmed, and ultrathin sections of the cells of interest were taken and examined by transmission EM to confirm virus infection. The region of interest was then excised and mounted with conductive silver epoxy resin onto specimen pins. Samples were further trimmed before being coated with gold palladium and mounted in the 3View microtome (Gatan, CA, USA) coupled to a Sigma VP scanning electron microscope (SEM; Zeiss, Cambridge, UK). Once aligned, the sample and microtome were returned to the SEM chamber and pumped to a vacuum pressure of 5 Pa. The region of interest on the block face was re-located in the SEM using backscattered electron detection and the imaging and cutting parameters were optimised. The voltage was set at 2 kV using the high current setting and a 20 μ aperture, and imaging parameters were set at 8 k × 8 k pixels, with a horizontal field width of 32.8 μm and a pixel size of 4 nm, with a slice thickness of 50 nm. For segmentation, datasets were imported into Amira (FEI VSG, France), and cells of interest were manually segmented, reconstructed and rendered in 3D. The locations of virus buds were manually marked on the sections using the TrakEM2 module of ImageJ, coordinates of the virus particles were calculated using a custom python script  and loaded into Amira for visualization.
EM, electron microscopy; ESCRT, endosomal sorting complexes required for transport; IPMC, intracellular plasma membrane-connected compartment; MDM, monocyte-derived macrophage; PtdIns(4,5)P2, phosphatidylinositol-4,5-bisphosphate
The authors thank Jim Hoxie and Wes Sundquist for plasmids and antibodies, and the National Institute for Biological Standards and Control Centre for AIDS Reagents (CFAR) for HIV antibodies. We thank Jane Turner and Steffy Czieso for preparing macrophages, Janos Kriston-Vizi for support and advice on image analysis and Ortrud Wartlick and Albert Cardona for scripts for image analysis. We also are grateful to Stuart Weston, Scott Lawrence and Michela Mazzon for critical comments on the manuscript and to Petra Mlcochova, Joe Grove and Sebastian Giese for laboratory support and discussions. DON was supported by the BIUST/Botswana Government PhD Fellowship. AP-M, JJB and MM are supported by UK Medical Research Council core funding to the MRC-UCL LMCB University Unit (Grant ref. MC_U122665002). LMC would like to acknowledge funding from Cancer Research UK, and from the MRC, BBSRC and EPSRC under grant award MR/K01580X/1.
DON, AP-M, JJB and MM designed the experiments. DON, AP-M, JJB and LMC performed the experiments. DON, AP-M, JJB and analysed the data. DON, AP-M, JJB and MM wrote the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Benaroch P, Billard E, Gaudin R, Schindler M, Jouve M. HIV-1 assembly in macrophages. Retrovirology. 2010;7:29.View ArticlePubMedPubMed CentralGoogle Scholar
- Tan J, Sattentau QJ. The HIV-1-containing macrophage compartment: a perfect cellular niche? Trends Microbiol. 2013;21(8):405–12.View ArticlePubMedGoogle Scholar
- Mariani C, Desdouits M, Favard C, Benaroch P, Muriaux DM. Role of Gag and lipids during HIV-1 assembly in CD4(+) T cells and macrophages. Front Microbiol. 2014;5:312.View ArticlePubMedPubMed CentralGoogle Scholar
- Deneka M, Pelchen-Matthews A, Byland R, Ruiz-Mateos E, Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol. 2007;177(2):329–41.View ArticlePubMedPubMed CentralGoogle Scholar
- Jouve M, Sol-Foulon N, Watson S, Schwartz O, Benaroch P. HIV-1 buds and accumulates in “nonacidic” endosomes of macrophages. Cell Host Microbe. 2007;2(2):85–95.View ArticlePubMedGoogle Scholar
- Welsch S, Groot F, Krausslich HG, Keppler OT, Sattentau QJ. Architecture and regulation of the HIV-1 assembly and holding compartment in macrophages. J Virol. 2011;85(15):7922–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Pelchen-Matthews A, Giese S, Mlcochova P, Turner J, Marsh M. beta2 integrin adhesion complexes maintain the integrity of HIV-1 assembly compartments in primary macrophages. Traffic. 2012;13(2):273–91.View ArticlePubMedGoogle Scholar
- Gaudin R, Berre S, Cunha de Alencar B, Decalf J, Schindler M, Gobert FX, et al. Dynamics of HIV-containing compartments in macrophages reveal sequestration of virions and transient surface connections. PLoS One. 2013;8:e69450.View ArticlePubMedPubMed CentralGoogle Scholar
- Mlcochova P, Pelchen-Matthews A, Marsh M. Organization and regulation of intracellular plasma membrane-connected HIV-1 assembly compartments in macrophages. BMC Biol. 2013;11:89.View ArticlePubMedPubMed CentralGoogle Scholar
- Welsch S, Keppler OT, Habermann A, Allespach I, Krijnse-Locker J, Krausslich HG. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 2007;3(3):e36.View ArticlePubMedPubMed CentralGoogle Scholar
- Berre S, Gaudin R, Cunha de Alencar B, Desdouits M, Chabaud M, Naffakh N, et al. CD36-specific antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells. J Exp Med. 2013;210(12):2523–38.View ArticlePubMedPubMed CentralGoogle Scholar
- Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science. 1997;276(5320):1857–61.View ArticlePubMedGoogle Scholar
- Johnson EL, Chu H, Byrareddy SN, Spearman P, Chakraborty R. Placental Hofbauer cells assemble and sequester HIV-1 in tetraspanin-positive compartments that are accessible to broadly neutralizing antibodies. J Int AIDS Soc. 2015;18(1):19385.PubMedPubMed CentralGoogle Scholar
- Ladinsky MS, Kieffer C, Olson G, Deruaz M, Vrbanac V, Tager AM, et al. Electron tomography of HIV-1 infection in gut-associated lymphoid tissue. PLoS Pathog. 2014;10(1):e1003899.View ArticlePubMedPubMed CentralGoogle Scholar
- Gousset K, Ablan SD, Coren LV, Ono A, Soheilian F, Nagashima K, et al. Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog. 2008;4(3):e1000015.View ArticlePubMedPubMed CentralGoogle Scholar
- Groot F, Welsch S, Sattentau QJ. Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood. 2008;111(9):4660–3.View ArticlePubMedGoogle Scholar
- Duncan CJ, Williams JP, Schiffner T, Gartner K, Ochsenbauer C, Kappes J, et al. High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse. J Virol. 2014;88(4):2025–34.View ArticlePubMedPubMed CentralGoogle Scholar
- Giese S, Marsh M. Tetherin can restrict cell-free and cell-cell transmission of HIV from primary macrophages to T cells. PLoS Pathog. 2014;10(7):e1004189.View ArticlePubMedPubMed CentralGoogle Scholar
- Duncan CJ, Sattentau QJ. Viral determinants of HIV-1 macrophage tropism. Viruses. 2011;3(11):2255–79.View ArticlePubMedPubMed CentralGoogle Scholar
- Gras G, Kaul M. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology. 2010;7:30.View ArticlePubMedPubMed CentralGoogle Scholar
- Rao VR, Ruiz AP, Prasad VR. Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res Ther. 2014;11:13.View ArticlePubMedPubMed CentralGoogle Scholar
- Williams DW, Veenstra M, Gaskill PJ, Morgello S, Calderon TM, Berman JW. Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders. Curr HIV Res. 2014;12(2):85–96.View ArticlePubMedPubMed CentralGoogle Scholar
- Gray LR, Roche M, Flynn JK, Wesselingh SL, Gorry PR, Churchill MJ. Is the central nervous system a reservoir of HIV-1? Curr Opin HIV AIDS. 2014;9(6):552–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Piguet V, Caucheteux SM, Iannetta M, Hosmalin A. Altered antigen-presenting cells during HIV-1 infection. Curr Opin HIV AIDS. 2014;9(5):478–84.View ArticlePubMedGoogle Scholar
- Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc Natl Acad Sci U S A. 2004;101(41):14889–94.View ArticlePubMedPubMed CentralGoogle Scholar
- Saad JS, Miller J, Tai J, Kim A, Ghanam RH, Summers MF. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc Natl Acad Sci U S A. 2006;103(30):11364–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Ghanam RH, Samal AB, Fernandez TF, Saad JS. Role of the HIV-1 matrix protein in Gag intracellular trafficking and targeting to the plasma membrane for virus assembly. Front Microbiol. 2012;3:55.View ArticlePubMedPubMed CentralGoogle Scholar
- Sharova N, Swingler C, Sharkey M, Stevenson M. Macrophages archive HIV-1 virions for dissemination in trans. EMBO J. 2005;24(13):2481–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Demirov DG, Orenstein JM, Freed EO. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J Virol. 2002;76(1):105–17.View ArticlePubMedPubMed CentralGoogle Scholar
- Fisher RD, Chung HY, Zhai Q, Robinson H, Sundquist WI, Hill CP. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell. 2007;128(5):841–52.View ArticlePubMedGoogle Scholar
- Votteler J, Sundquist WI. Virus budding and the ESCRT pathway. Cell Host Microbe. 2013;14(3):232–41.View ArticlePubMedGoogle Scholar
- Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell. 2001;107(1):55–65.View ArticlePubMedGoogle Scholar
- Martin-Serrano J, Zang T, Bieniasz PD. Role of ESCRT-I in retroviral budding. J Virol. 2003;77(8):4794–804.View ArticlePubMedPubMed CentralGoogle Scholar
- von Schwedler UK, Stuchell M, Muller B, Ward DM, Chung HY, Morita E, et al. The protein network of HIV budding. Cell. 2003;114(6):701–13.View ArticleGoogle Scholar
- Huang M, Orenstein JM, Martin MA, Freed EO. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol. 1995;69(11):6810–8.PubMedPubMed CentralGoogle Scholar
- Carlson LA, de Marco A, Oberwinkler H, Habermann A, Briggs JA, Krausslich HG, et al. Cryo electron tomography of native HIV-1 budding sites. PLoS Pathog. 2010;6(11):e1001173.View ArticlePubMedPubMed CentralGoogle Scholar
- Denk W, Horstmann H. Serial block-face scanning electron microscopy to reconstruct three-dimensional tissue nanostructure. PLoS Biol. 2004;2(11):e329.View ArticlePubMedPubMed CentralGoogle Scholar
- Fujii K, Munshi UM, Ablan SD, Demirov DG, Soheilian F, Nagashima K, et al. Functional role of Alix in HIV-1 replication. Virology. 2009;391(2):284–92.View ArticlePubMedPubMed CentralGoogle Scholar
- Pettit SC, Everitt LE, Choudhury S, Dunn BM, Kaplan AH. Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism. J Virol. 2004;78(16):8477–85.View ArticlePubMedPubMed CentralGoogle Scholar
- Olety B, Veatch SL, Ono A. Phosphatidylinositol-(4,5)-bisphosphate acyl chains differentiate membrane binding of HIV-1 Gag from That of the Phospholipase Cdelta1 pleckstrin homology domain. J Virol. 2015;89(15):7861–73.View ArticlePubMedPubMed CentralGoogle Scholar
- Bennett AE, Narayan K, Shi D, Hartnell LM, Gousset K, He H, et al. Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathog. 2009;5(9):e1000591.View ArticlePubMedPubMed CentralGoogle Scholar
- Koppensteiner H, Banning C, Schneider C, Hohenberg H, Schindler M. Macrophage internal HIV-1 is protected from neutralizing antibodies. J Virol. 2012;86(5):2826–36.View ArticlePubMedPubMed CentralGoogle Scholar
- Meissner EG, Duus KM, Gao F, Yu XF, Su L. Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope. Virology. 2004;328(1):74–88.View ArticlePubMedPubMed CentralGoogle Scholar
- Pelchen-Matthews A, Marsh M. Electron microscopy analysis of viral morphogenesis. Methods Cell Biol. 2007;79:515–42.View ArticlePubMedGoogle Scholar
- Slot JW, Geuze HJ. Cryosectioning and immunolabeling. Nat Protoc. 2007;2(10):2480–91.View ArticlePubMedGoogle Scholar
- TrackEM2 scripting: Cardona, A. Export all Ball objects as a CSV file http://fiji.sc/TrakEM2_Scripting#Export_all_Ball_objects_as_a_CSV_file. Accessed 10 Dec 2015.